You just read:

Zimmer Biomet Reports Positive Update on Biologics Pipeline Following a Preliminary Analysis of Data from the First Pivotal Trial of Stem Cell Therapy for Critical Limb Ischemia to Reach Completion

News provided by

Zimmer Biomet Holdings, Inc.

Nov 15, 2016, 08:00 ET